glp 1 and kidney disease Glucagon-like peptide-1 receptor signaling modifies the extent of diabetic through dampening the receptor for advanced glycation end products–induced inflammation GLP-1 RAs, Other Agents, Underused

C., Ding, C., & Magkos, F

Wegovy offered a way out

Some people notice a real difference simply by switching from morning to evening, or vice versa

Continuous GLP-1RA Use Reduces MACE Risk Incident use of GLP-1RAs was associated with a lower risk of MACE compared to incident use of sulfonylureas

Material and methods Study design and population We applied a new-user, active comparator cohort study design, comparing GLP-1 RA users with SGLT-2 inhibitor users and GLP-1 RA users with DPP-4 inhibitor users on the incidence of suicide or suicide attempts [19], utilizing information from registers on the entire Danish population [20]